<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367477"><TermName>lobradimil</TermName><TermPronunciation>(loh-BRAY-dih-mil)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied for its ability to help other drugs reach the brain. It belongs to the family of drugs called bradykinin agonists. Also called RMP-7.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731319" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lobradimil&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731318" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lobradimil&quot;" language="es" id="_4"/><SpanishTermName>lobradimil</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad de ayudar a que otros medicamentos lleguen al cerebro. Es un tipo de agonista de la bradicinina. Tambi√©n se llama RMP-7.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished></GlossaryTerm>
